The Efficacy of FDG-PET for the Management of Esophageal Cancer: Review Article

被引：31

作者：

Kato, Hiroyuki ^{[1
]}

Nakajima, Masanobu ^{[1
]}

机构：

[1] Dokkyo Med Univ, Dept Surg 1, Mibu, Tochigi 3210293, Japan

来源：

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY | 2012年 / 18卷 / 05期

关键词：

esophageal cancer; FDG-PET; PET/CT; SUV; staging; POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; NEOADJUVANT CHEMORADIOTHERAPY; DEFINITIVE CHEMORADIOTHERAPY; THORACIC ESOPHAGUS; COMPLETE RESPONSE; PHASE-II; PREOPERATIVE CHEMOTHERAPY; COMPUTED-TOMOGRAPHY; DISTANT METASTASES;

D O I：

10.5761/atcs.ra.12.01954

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

F-18-Fluorodeoxyglucose positron emission tomography has become an important informative modality during the past two decades. Because this type of tomography is a functional imaging construct, its primary use is in the field of oncology. It is being used increasingly in the management of several tumor types including esophageal cancer. These tomography scans can distinguish between benign and malignant tumors, identify stages of tumor spread, assess tumor recurrence, and monitor the response of malignant disease to therapy. The aim of this review was to outline the current and future roles of positron emission tomography in the management of esophageal cancer.

引用

页码：412 / 419

页数：8

共 69 条

[1]

[Anonymous], 2005, Esophagus, DOI DOI 10.1007/S10388-005-0060-6

[2] Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival [J].

Berger, AC ;

Farma, J ;

Scott, WJ ;

Freedman, G ;

Weiner, L ;

Cheng, JD ;

Wang, H ;

Goldberg, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4330-4337

[3] A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer [J].

Blackstock, AW ;

Farmer, MR ;

Lovato, J ;

Mishra, G ;

Melin, SA ;

Oaks, T ;

Aklilu, M ;

Clark, PB ;

Levine, EA .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :455-460

[4] Improvement in staging of esophageal cancer with the addition of positron emission tomography [J].

Block, MI ;

Patterson, GA ;

Sundaresan, RS ;

Bailey, MS ;

Flanagan, FL ;

Dehdashti, F ;

Siegel, BA ;

Cooper, JD .

ANNALS OF THORACIC SURGERY, 1997, 64 (03) :770-776

[5] Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma:: results of a prospective phase-II trial [J].

Brücher, BLDM ;

Stein, HJ ;

Zimmermann, F ;

Werner, M ;

Sarbia, M ;

Busch, R ;

Dittler, HJ ;

Molls, M ;

Fink, U ;

Siewert, JR .

EJSO, 2004, 30 (09) :963-971

[6]

Brücher BLDM, 2001, ANN SURG, V233, P300

[7] Detection of bone metastases in breast cancer by 18FDG PET:: Differing metabolic activity in osteoblastic and osteolytic lesions [J].

Cook, GJ ;

Houston, S ;

Rubens, R ;

Maisey, MN ;

Fogelman, I .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3375-3379

[8] Neoplasms of the esophagus and stomach [J].

Dehdashti, F ;

Siegel, BA .

SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (03) :198-208

[9]

Duhaylongsod FG, 1997, ANN THORAC SURG, V64, P776

[10] Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer [J].

Duong, Cuong P. ;

Demitriou, Helen ;

Weih, LeAnn ;

Thompson, Anne ;

Williams, David ;

Thomas, Robert J. S. ;

Hicks, Rodney J. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (07) :759-769

← 1 2 3 4 5 6 7 →